Study shows how naturally occurring compound kills drug resistant bacteria

Antimicrobial resistance occurs when bacteria evolve and stop responding to drugs over time

Image
ANI Science
3 min read Last Updated : Oct 29 2022 | 11:11 AM IST

Scientists studying how an organic molecule affects bacteria that are resistant to drugs have found that it can suppress and destroy a pathogen that can cause significant disease or, in some circumstances, death.

Often seen in hospital patients, Pseudomonas aeruginosa is a type of bacteria that can cause infections in the blood, lungs (pneumonia), or other regions of the body following surgery.

Recently, it was shown that the germ and several other clinically significant bacteria, including as Staphylococcus aureus, Escherichia coli, and Klebsiella pneumonia, were susceptible to the bacterial killing action of hydroquinone, an organic chemical found in the bark of some trees.

The research team, made up of members from the University of Portsmouth, Naresuan University, and Pibulsongkram Rajabhat University in Thailand, has since looked at the molecular reactions of various strains of Pseudomonas aeruginosa to hydroquinone. In order to do this, they examined which genes the medication activated and which ones it turned off.

Hydroquinone drastically changes the expression levels of virulence factors in Pseudomonas aeruginosa, according to a recent study published in the journal Antibiotics. Additionally, it implies that the substance obstructs the assembly and movement of the germs.

Dr. Robert Baldock from the School of Pharmacy and Biomedical Sciences at the University of Portsmouth, said: "There's quite a long list of antibiotics that don't work on Pseudomonas. aeruginosa, but our experiments found some of the genes governing the motility of the bacterium were quite drastically switched off by hydroquinone. Biofilm formation and the swarming and swimming off the germ were significantly reduced.

"If we know that this drug is working in a really unique or different way then it firstly explains why it's active on these drug-resistant cells, but it also means that you can potentially look at combining it with other existing antibiotics to make them more effective."

More than 2.8 million infections are caused by drug-resistant bacteria, which also cause 35,000 fatalities each year. Antimicrobial resistance occurs when bacteria evolve and stop responding to drugs over time, making it challenging to treat infections.

Antibiotics that are often used yet to which some strains of Pseudomonas aeruginosa have developed resistance include amoxicillin and trimethoprim. In addition to being used to treat nocturnal muscle cramps in the Netherlands, hydroquinine is already recognised to be an effective treatment for human malaria. Little research has been done up until now on its drug-resistant traits.

Dr Jirapas Jongjitwimol from the Department of Medical Technology at Naresuan University added: "Antimicrobial resistance has become one of the greatest threats to public health globally, so to discover an organic compound has the potential to be used as an effective weapon in the fight is very exciting.

"We now need to look at how the compound works against a wider variety of bacterial strains so that we better understand why some germs are affected or not affected by it.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :ScienceMedicineshealthcare

First Published: Oct 29 2022 | 11:11 AM IST

Next Story